20:07:27 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



AEterna Zentaris Inc (2)
Symbol AEZ
Shares Issued 56,513,969
Close 2014-04-29 C$ 1.24
Market Cap C$ 70,077,322
Recent Sedar Documents

ORIGINAL: Aeterna Zentaris to Announce First Quarter 2014 Financial and Operating Results on May 8, 2014 and Hold Annual Shareholders Meeting on May 9, 2014

2014-04-30 08:16 ET - News Release

Aeterna Zentaris to Announce First Quarter 2014 Financial and Operating Results on May 8, 2014 and Hold Annual Shareholders Meeting on May 9, 2014

Canada NewsWire

QUEBEC CITY, April 30, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its first quarter 2014 financial and operating results after market close on Thursday, May 8, 2014. The Company will host a conference call to discuss these results on Friday, May 9, 2014, at 8:30 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

The Company further announced that it will hold its Annual Shareholders Meeting also on Friday, May 9, 2014, starting at 10:30 a.m., Eastern Time, at the offices of Norton Rose Fulbright Canada, 1 Place Ville-Marie, Suite 2500, in Montreal, Canada.

About Aeterna Zentaris

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds at various stages of development. For more information, visit www.aezsinc.com.

SOURCE Aeterna Zentaris Inc.

Contact:

<p> Paul Burroughs<br/> Director of Communications<br/> (418) 652-8525 ext. 406<br/> <a href="mailto:pburroughs@aezsinc.com">pburroughs@aezsinc.com</a> </p>

© 2024 Canjex Publishing Ltd. All rights reserved.